MARKETS
PERPS
LIVE
133
SOCIAL
TRUST
RESEARCH
Cash
Browse
Live
133
Portfolio
Search
Social
Log in
Sign up
Trending
Elections
Politics
Sports
Culture
Crypto
Commodities
Climate
Economics
Mentions
Finance
Tech & Science
Browse
Live
133
Portfolio
Search
Social
Trending
Elections
Politics
Sports
Culture
Crypto
Commodities
Climate
Economics
Mentions
Finance
Tech & Science
All markets
2026 Mega IPOs
Companies
CEOs
IPOs
KPIs
M&A
Product launches
Industries
Healthcare
Technology
Markets
Foreign Exchange
Indices
Interest Rates
Match Ups
Industries
Trending
Frequency
Industries
NVIDIA B200 · Hourly price on Jul 17 (Week 29)
Above $7.50
2.66
x
37
%
Above $7.00
1.29
x
71
%
$54,919 vol
13 markets
Industries
NVIDIA RTX 5090 · Hourly price on Jul 17 (Week 29)
Above $0.50
1.22
x
73
%
Above $0.75
18.8
x
5
%
$51,650 vol
6 markets
Industries
NVIDIA H200 · Average hourly price in July
Above $4.50
2.34
x
35
%
Above $4.00
1.12
x
89
%
$46,366 vol
11 markets
Industries
NVIDIA H100 · Hourly price on Jul 17 (Week 29)
Above $2.75
3.40
x
28
%
Above $2.50
1.25
x
73
%
$8,352 vol
9 markets
Industries
NVIDIA RTX 5090 · Average hourly price in July
Above $0.50
1.46
x
73
%
Above $0.75
7.25
x
13
%
$21,570 vol
7 markets
Industries
NVIDIA H200 · Hourly price on Jul 17 (Week 29)
Above $4.50
1.57
x
62
%
Above $5.00
10.4
x
9
%
$19,492 vol
9 markets
Industries
NVIDIA A100 · Hourly price on Jul 17 (Week 29)
Above $1.00
1.12
x
89
%
Above $1.25
13.4
x
4
%
$23,504 vol
7 markets
Industries
NVIDIA H100 · Average hourly price in July
Above $2.50
1.33
x
60
%
Above $3.00
23.4
x
4
%
$2,721 vol
9 markets
Industries
NVIDIA B200 · Average hourly price in July
Above $6.50
1.48
x
53
%
Above $7.00
5.90
x
13
%
$27,013 vol
9 markets
Industries
NVIDIA A100 · Average hourly price in July
Above $1.00
1.26
x
88
%
Above $1.25
4.73
x
1
%
$14,371 vol
7 markets
Industries
FDA decision: Ivonescimab by Summit Therapeutics (this year)
Yes
1.62
x
53
%
No
2.05
x
47
%
$470 vol
1 market
Industries
FDA decision: Iberdomide by Celgene (this year)
Yes
1.34
x
67
%
No
2.98
x
33
%
$614 vol
1 market
Industries
FDA decision: Zidesamtinib by Nuvalent (this year)
Yes
1.25
x
79
%
No
3.52
x
21
%
$100 vol
1 market
Industries
FDA decision: Venglustat by Sanofi (this year)
Yes
1.15
x
85
%
No
4.51
x
15
%
$0 vol
1 market
Industries
FDA decision: Saroglitazar by Zydus Therapeutics (this year)
Yes
1.31
x
75
%
No
3.08
x
25
%
$131 vol
1 market
Industries
FDA decision: Rusfertide by Protagonist Therapeutics (this year)
Yes
1.10
x
84
%
No
6.29
x
16
%
$114 vol
1 market
Industries
FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (this year)
Yes
1.22
x
74
%
No
3.80
x
26
%
$30 vol
1 market
Industries
FDA decision: DTX401 (pariglasgene brecaparvovec) by Ultragenyx Pharmaceutical (this year)
Yes
1.44
x
62
%
No
2.59
x
38
%
$90 vol
1 market
Industries
What will the price of TrendForce’s DDR5 be at year-end 2027?
Above $45.00
1.73
x
56
%
Above $55.00
2.24
x
39
%
$3,612 vol
9 markets
Industries
FDA decision: Brepocitinib by Priovant Therapeutics (this year)
Yes
1.22
x
74
%
No
3.80
x
26
%
$47 vol
1 market
Industries
FDA decision: bictegravir 75 mg/lenacapavir 50 mg (BIC/LEN) by Gilead Sciences (this year)
Yes
1.05
x
95
%
No
9.41
x
5
%
$11 vol
1 market
Industries
FDA decision: Bepirovirsen by GlaxoSmithKline (this year)
Yes
1.29
x
76
%
No
3.18
x
24
%
$64 vol
1 market
Industries
FDA decision: BBP-418 by Ml Bio Solutions Inc. (this year)
Yes
1.06
x
89
%
No
8.56
x
11
%
$18 vol
1 market
Industries
FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (this year)
Yes
1.23
x
79
%
No
3.80
x
21
%
$458 vol
1 market